Autopsy report · NCT02559193

Pharmacogenetic Testing for Medication Management.

“Loss of funding for the continuation of the Study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

First Vitals LLC

Sponsor type

Industry

Conditions

Medication Management

Interventions

Observational study, data collection only trial.

Participants

0

Trials that died the same way

• A Commercial Available Tooth Positioner for the Treatment of Simple Orthodontic Relapse
  “losing of funding for the study” (91% match in meaning)
• Abuse Potential of Buprenorphine/Naloxone
  “Funding ended for the study” (89% match in meaning)
• Therapeutic Exercise in Patients With Hemophilia
  “The Study was terminated due to lack of funding for continuing” (85% match in meaning)
• Transverse Abdominal Plane Anesthesia for Abdominal Wall Reconstruction
  “funding for the study was terminated” (85% match in meaning)
• Managing Chronic Tendon Pain by Metformin
  “The study funding has ended.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.